Rapport Therapeutics, Inc. (RAPP) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Rapport Therapeutics, Inc. (RAPP) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Rapport Therapeutics, Inc.

· RAPP

Dashboard

Financials

Ratios

Valuation

Statistics

1.584 B

+1.76%

General

Market Cap: $1.58B
Enterprise Value: $1.55B
Shares Outstanding: 47,830,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 100.00%
Operating Margin: -767.58%
Net Profit Margin: -685.80%
FCF Margin: -485.75%
ROA: -29.88%
ROE: -29.02%
ROIC: -35.45%
Current Ratio: 15.72
Debt-to-Equity: 0.02
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.46
P/S: 80.35
P/FCF: —
P/B: 3.80
EV/EBITDA: -10.49

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —

Income Statement (TTM)

Revenue: $20M
Gross Margin: 100.00%
Operating Expenses: $173.52M
Operating Income: -$153.52M
Net Profit: -$137.16M

Balance Sheet

EPS 10Y (CAGR)

—

Cash and Equivalents: $63.61M
Working Capital: $418.43M
Total Assets: $458.98M
Net Debt: -$53.51M
Total Liabilities: $36.06M
Total Equity: $422.93M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$96.68M
Cash Flow from Investing: -$167.56M
Cash Flow from Financing: $272.79M
Free Cash Flow: -$97.15M
Capital Expenditures: $467K